163 related articles for article (PubMed ID: 34165723)
1. Pseudogene Profiling for Cancer Subtype Classification.
Zhang Y; Zheng D
Methods Mol Biol; 2021; 2324():307-317. PubMed ID: 34165723
[TBL] [Abstract][Full Text] [Related]
2. Pseudogenes: newly discovered players in human cancer.
Poliseno L
Sci Signal; 2012 Sep; 5(242):re5. PubMed ID: 22990117
[TBL] [Abstract][Full Text] [Related]
3. PseudoFuN: Deriving functional potentials of pseudogenes from integrative relationships with genes and microRNAs across 32 cancers.
Johnson TS; Li S; Franz E; Huang Z; Dan Li S; Campbell MJ; Huang K; Zhang Y
Gigascience; 2019 May; 8(5):. PubMed ID: 31029062
[TBL] [Abstract][Full Text] [Related]
4. Pseudogene-expressed RNAs: a new frontier in cancers.
Shi X; Nie F; Wang Z; Sun M
Tumour Biol; 2016 Feb; 37(2):1471-8. PubMed ID: 26662308
[TBL] [Abstract][Full Text] [Related]
5. Pseudogenes transcribed in breast invasive carcinoma show subtype-specific expression and ceRNA potential.
Welch JD; Baran-Gale J; Perou CM; Sethupathy P; Prins JF
BMC Genomics; 2015 Feb; 16(1):113. PubMed ID: 25765044
[TBL] [Abstract][Full Text] [Related]
6. Pseudogenes as Biomarkers and Therapeutic Targets in Human Cancers.
Sisu C
Methods Mol Biol; 2021; 2324():319-337. PubMed ID: 34165724
[TBL] [Abstract][Full Text] [Related]
7. The Pan-Cancer analysis of pseudogene expression reveals biologically and clinically relevant tumour subtypes.
Han L; Yuan Y; Zheng S; Yang Y; Li J; Edgerton ME; Diao L; Xu Y; Verhaak RGW; Liang H
Nat Commun; 2014 Jul; 5():3963. PubMed ID: 24999802
[TBL] [Abstract][Full Text] [Related]
8. Pseudogene Transcripts in Head and Neck Cancer: Literature Review and
Carron J; Della Coletta R; Lourenço GJ
Genes (Basel); 2021 Aug; 12(8):. PubMed ID: 34440428
[TBL] [Abstract][Full Text] [Related]
9. Methods for the Detection of Circulating Pseudogenes and Their Use as Cancer Biomarkers.
Vaidya M; Sugaya K
Methods Mol Biol; 2021; 2324():339-360. PubMed ID: 34165725
[TBL] [Abstract][Full Text] [Related]
10. Identification of Potential Diagnostic and Prognostic Pseudogenes in Hepatocellular Carcinoma Based on Pseudogene-miRNA-mRNA Competitive Network.
Yan L; Yue C; Xu Y; Jiang X; Zhang L; Wu J
Med Sci Monit; 2020 May; 26():e921895. PubMed ID: 32457285
[TBL] [Abstract][Full Text] [Related]
11. Relevant genomics of neurotensin receptor in cancer.
Elek J; Pinzon W; Park KH; Narayanan R
Anticancer Res; 2000; 20(1A):53-8. PubMed ID: 10769634
[TBL] [Abstract][Full Text] [Related]
12. Network analysis of pseudogene-gene relationships: from pseudogene evolution to their functional potentials.
Johnson TS; Li S; Kho JR; Huang K; Zhang Y
Pac Symp Biocomput; 2018; 23():536-547. PubMed ID: 29218912
[TBL] [Abstract][Full Text] [Related]
13. Application of Machine Learning in Developing a Novelty Five-Pseudogene Signature to Predict Prognosis of Head and Neck Squamous Cell Carcinoma: A New Aspect of "Junk Genes" in Biomedical Practice.
Xing L; Zhang X; Guo M; Zhang X; Liu F
DNA Cell Biol; 2020 Apr; 39(4):709-723. PubMed ID: 32045271
[TBL] [Abstract][Full Text] [Related]
14. Re-recognition of pseudogenes: From molecular to clinical applications.
Chen X; Wan L; Wang W; Xi WJ; Yang AG; Wang T
Theranostics; 2020; 10(4):1479-1499. PubMed ID: 32042317
[TBL] [Abstract][Full Text] [Related]
15. The pseudogene-derived long non-coding RNA SFTA1P suppresses cell proliferation, migration, and invasion in gastric cancer.
Ma H; Ma T; Chen M; Zou Z; Zhang Z
Biosci Rep; 2018 Apr; 38(2):. PubMed ID: 29523596
[TBL] [Abstract][Full Text] [Related]
16. Gene expression profiling defines molecular subtypes of classical Hodgkin's disease.
Devilard E; Bertucci F; Trempat P; Bouabdallah R; Loriod B; Giaconia A; Brousset P; Granjeaud S; Nguyen C; Birnbaum D; Birg F; Houlgatte R; Xerri L
Oncogene; 2002 May; 21(19):3095-102. PubMed ID: 12082542
[TBL] [Abstract][Full Text] [Related]
17. Functional roles of pseudogenes in cancers.
Tang JS; Yang MY; Li Y
Yi Chuan; 2015 Jan; 37(1):8-16. PubMed ID: 25608808
[TBL] [Abstract][Full Text] [Related]
18. The pseudogene-derived long noncoding RNA SFTA1P is down-regulated and suppresses cell migration and invasion in lung adenocarcinoma.
Zhang H; Xiong Y; Xia R; Wei C; Shi X; Nie F
Tumour Biol; 2017 Feb; 39(2):1010428317691418. PubMed ID: 28231733
[TBL] [Abstract][Full Text] [Related]
19. Translating metastasis-related biomarkers to the clinic--progress and pitfalls.
Bidard FC; Pierga JY; Soria JC; Thiery JP
Nat Rev Clin Oncol; 2013 Mar; 10(3):169-79. PubMed ID: 23381003
[TBL] [Abstract][Full Text] [Related]
20. CRIPTO3, a presumed pseudogene, is expressed in cancer.
Sun C; Orozco O; Olson DL; Choi E; Garber E; Tizard R; Szak S; Sanicola M; Carulli JP
Biochem Biophys Res Commun; 2008 Dec; 377(1):215-20. PubMed ID: 18835250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
